ID: ALA4289740

Max Phase: Preclinical

Molecular Formula: C36H32N6O5S

Molecular Weight: 660.76

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOc1ccc(OC)cc1C1(N2CCN(c3ccncc3)CC2)C(=O)N(S(=O)(=O)c2cccc3cccnc23)c2ccc(C#N)cc21

Standard InChI:  InChI=1S/C36H32N6O5S/c1-3-47-32-12-10-28(46-2)23-30(32)36(41-20-18-40(19-21-41)27-13-16-38-17-14-27)29-22-25(24-37)9-11-31(29)42(35(36)43)48(44,45)33-8-4-6-26-7-5-15-39-34(26)33/h4-17,22-23H,3,18-21H2,1-2H3

Standard InChI Key:  KSMVBENPNMJAKN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 660.76

Molecular Weight (Monoisotopic): 660.2155

AlogP: 4.71

#Rotatable Bonds: 8

Polar Surface Area: 128.96

Molecular Species: BASE

HBA: 10

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 8.70

CX LogP: 4.54

CX LogD: 3.71

Aromatic Rings: 5

Heavy Atoms: 48

QED Weighted: 0.23

Np Likeness Score: -1.11

References

1. Geneste H, Bhowmik S, van Gaalen MM, Hornberger W, Hutchins CW, Netz A, Oost T, Unger L..  (2018)  Novel, potent, selective and brain penetrant vasopressin 1b receptor antagonists.,  28  (19): [PMID:30098866] [10.1016/j.bmcl.2018.07.043]

Source

Source(1):

• Scientific Literature